We could add it to the list of the recently discovered new targets with mechanistic links to atherothrombotic heart disease, such as proteins involved in glycoprotein recognition and clearance, regulators of triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and the gut microbiome56. This evidence concerns the gene ART4 and heart disorder.